Gordon M. Binder - 02 Sep 2022 Form 4 Insider Report for Humacyte, Inc. (HUMA)

Role
Director
Signature
/s/ Gordon M. Binder by Dale A. Sander as Attorney-in-Fact
Issuer symbol
HUMA
Transactions as of
02 Sep 2022
Net transactions value
+$272,100
Form type
4
Filing time
06 Sep 2022, 16:14:39 UTC
Previous filing
01 Sep 2022
Next filing
16 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HUMA Common Stock Purchase $272,100 +61,841 +128% $4.40 110,000 02 Sep 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were purchased in multiple transactions at per share prices ranging from $4.20 to $4.70. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.